GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Notes Receivable

Curocell (XKRX:372320) Notes Receivable : ₩0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Notes Receivable?

Curocell's Notes Receivable for the quarter that ended in Jun. 2023 was ₩0.00 Mil.


Curocell Notes Receivable Historical Data

The historical data trend for Curocell's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Notes Receivable Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Notes Receivable - - - -

Curocell Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Curocell Notes Receivable Related Terms

Thank you for viewing the detailed overview of Curocell's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines